Ingrid A Boere

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Capecitabine has activity against several types of cancer. In 10-15% of patients treated with capecitabine, treatment is discontinued because of serious adverse reactions, mostly within the first weeks of treatment. A 56 year-old female patient presented at the emergency department after ten days of chemotherapy with progressive airway obstruction and(More)
  • 1